HLB´Â ¹Ì±¹ FDA¿¡ °£¾Ï 1Â÷ Ä¡·áÁ¦(¸®º¸¼¼¶ó´Õ,į·¼¸®ÁÖ¸¿ º´¿ë¿ä¹ý) Àç½ÂÀÎ ¼·ù¸¦ Á¦ÃâÇß´Ù°í 24ÀÏ °ø½ÃÇß´Ù.
ȸ»çÃøÀº "¹Ì±¹ ³» Á¾¼Óȸ»ç Elevar Therapeutics, Inc.´Â ÇöÁö½Ã°£ 09¿ù 20ÀÏ ¹Ì±¹ FDA¿¡ °£¾Ï 1Â÷ Ä¡·áÁ¦(¸®º¸¼¼¶ó´Õ,į·¼¸®ÁÖ¸¿ º´¿ë¿ä¹ý) ½Å¾àÇã°¡ Àç½ÂÀÎ ½Åû ¼·ù¸¦ Á¦ÃâÇÏ¿´´Ù"°í ¹àÇû´Ù.
¶Ç "Áö³ 05¿ù 17ÀÏ FDA·ÎºÎÅÍ ¹ÞÀº º¸¿Ï¿ä±¸¼ÇÑ(CRL,Complete Response Letter)¿¡ ´ëÇØ Àç½ÂÀÎ ½ÅûÀ» ÁøÇàÇÏ´Â »çÇ×À¸·Î ¼·ù Á¢¼ö ÈÄ FDA´Â ÆǴܱâÁØ(Class 1: 2°³¿ù, Class 2: 6°³¿ù)¿¡ µû¶ó ½É»ç±â°£À» Á¤ÇØ ½ÂÀÎ Çã°¡ ¿©ºÎ¸¦ °áÁ¤ÇÏ°Ô µÈ´Ù"°í µ¡ºÙ¿´´Ù.
¹Úº´¿ì ±âÀÚ bwpark0918@pharmstock.co.kr
<ÀúÀÛ±ÇÀÚ © ÆʽºÅ¹, ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö>